Using Personalized Assessments in the Treatment of Childhood OCD

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
Johns Hopkins University
Study ID
NCT06407648
Status
Recruiting

Conditions

  • Obsessive-Compulsive Disorder

Eligibility Criteria

Sex
ALL
Age
8 Years - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • Personalized Assessments — OTHER
    Personalized CBT will use individualized OCD symptom networks to guide CBT strategies to target central symptom nodes in contemporaneous networks.
  • Standard of Care — OTHER
    The standard CBT condition will use standard-of-care approaches to guide CBT strategies to target OCD symptoms.

Study Details

The primary purpose of this study is to learn whether personalized assessment of obsessive-compulsive disorder (OCD) symptoms in childhood OCD using mobile health technology are feasible and acceptable for youth and parents. The investigators will also examine whether personalized cognitive-behavioral therapy (CBT) that is informed by personalized OCD assessments yields better clinical outcomes when compared to standard CBT for youth with OCD

Key Dates

Start date
Apr 3, 2024
Status verified
May 2026
Primary completion
Jul 30, 2026
Completion
Dec 30, 2026

Study Design

Enrollment
30 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Personalized Assessments
    12 sessions of exposure with response prevention (ERP) that is guided by personalized assessments.
  • Active Comparator: Standard of Care
    12 sessions of exposure with response prevention (ERP) that is guided using standard practice.

Primary Outcome Measure

Children's Yale-Brown Obsessive-Compulsive Scale Second Edition (CY-BOCS-II) Total Severity Score [ Time Frame: Screen, Baseline (Week 0), Week 4, Week 8, and Week 12 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Johns Hopkins University School of MedicineBaltimoreMaryland21287
Joseph McGuire, PhD
443-287-7157

Find similar trials in Baltimore, MD

Related Studies